Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-427.32	-668.49	-126.77
Graham Fair Price	-60.93	1.45	3.72
PEG	5170.65	0.29	< 0.005
Price/Book	-8.74	2.72	2.98
Price/Cash Flow	98.97	-20.01	-1948.81
Prices/Earnings	-415.93	-24.59	-4.77
Price/Sales	20.80	3.08	2.55
Price/FCF	98.97	-20.01	-1948.81
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	14.06	0.12	0.10
Operating Margin	89.89	-0.02	-0.15
ROA	82.95	< 0.005	-0.04
ROE	-0.16	-0.03	82.31
ROIC	-0.06	< 0.005	91.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	0.05	41.86
Dividends QOQ	0.04	-0.65	1695.24
EBIT QOQ	-10.04	0.93	-90.75
EPS QOQ	-8.54	0.84	-90.21
FCF QOQ	-1.03	-82.18	-7843.66
Revenue QOQ	0.14	-0.29	102.92
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	42.45	61.81	45.62
Days Sales Outstanding (DSO)	19.11	30.06	57.29
Inventory Turnover	2.12	1.46	-31.33
Debt/Capitalization	0.62	0.64	3.82
Quick Ratio	0.43	0.34	-19.77
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.98	1.84	-7.11
Cash	1.15	0.75	-35.12
Capex	-0.07	-0.06	24.27
Free Cash Flow	< 0.005	-0.25	-8157.71
Revenue	2.32	1.63	-29.83
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.70	0.65	-6.14
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-32.97	-234.41	-611.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating